MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Oncogene

• Publication date

  2006-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1209364PMID 16462770
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Essential Role for Mitogen-activated Protein (MAP) Kinase Phosphatase-1 in Stress-responsive MAP Kinase and Cell Survival Signaling*

  2005influential reference
• Mitogen-Activated Protein Kinase Phosphatase-1 Is Overexpressed in Non-Small Cell Lung Cancer and Is an Independent Predictor of Outcome in Patients

  2004cited by this paper
• Inhibition of MKP-1 expression potentiates JNK related apoptosis in renal cancer cells.

  2004cited by this paper
• Evidence That Mitogen-Activated Protein Kinase Phosphatase-1 Induction by Proteasome Inhibitors Plays an Antiapoptotic Role

  2004cited by this paper
• Control of oncogenesis and cancer therapy resistance

  2004cited by this paper
• Down-regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity of pancreatic cancer cells.

  2003cited by this paper
• Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer.

  2003cited by this paper
• The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

  2002cited by this paper
• Expression of mitogen‐activated protein kinase phosphatase‐1 (MKP‐1) in primary human ovarian carcinoma

  2002cited by this paper
• Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines

  2002cited by this paper
• Transcriptional Induction of MKP-1 in Response to Stress Is Associated with Histone H3 Phosphorylation-Acetylation

  2001cited by this paper
• CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin

  2000cited by this paper
• RO 31-8220 activates c-Jun N-terminal kinase and glycogen synthase in rat adipocytes and L6 myotubes. Comparison to actions of insulin.

  1999cited by this paper
• Cell Stress and MKK6b-mediated p38 MAP Kinase Activation Inhibit Tumor Necrosis Factor-induced IκB Phosphorylation and NF-κB Activation*

  1999cited by this paper
• Human DU145 prostate cancer cells overexpressing mitogen-activated protein kinase phosphatase-1 are resistant to Fas ligand-induced mitochondrial perturbations and cellular apoptosis

  1999cited by this paper
• Lack of c‐Jun activity increases survival to cisplatin

  1999cited by this paper
• Cisplatin induces a persistent activation of JNK that is related to cell death

  1998cited by this paper
• Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention

  1997cited by this paper
• Induction of apoptosis by the transcription factor c‐Jun

  1997cited by this paper
• Mitogen-activated Protein Kinase Phosphatases Inactivate Stress-activated Protein Kinase Pathways in Vivo*

  1997cited by this paper
• The Selective Protein Kinase C Inhibitor, Ro-31-8220, Inhibits Mitogen-activated Protein Kinase Phosphatase-1 (MKP-1) Expression, Induces c-Jun Expression, and Activates Jun N-terminal Kinase*

  1996influential reference
• Role of Mitogen-activated Protein Kinase Phosphatase during the Cellular Response to Genotoxic Stress

  1995cited by this paper
• A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death.

  1995influential reference
• An emerging family of dual specificity MAP kinase phosphatases.

  1995cited by this paper
• The stress-activated protein kinase subfamily of c-Jun kinases

  1994cited by this paper
• JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

  1994cited by this paper
• Tumor suppressor and immediate early transcription factor genes in non-small cell lung cancer.

  1994cited by this paper
• Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.

  1993cited by this paper
• Interstrand cross-links and sequence specificity in the reaction of cis-dichloro(ethylenediamine)platinum(II) with DNA.

  1985cited by this paper
• Printed in U.S.A. Copyright © 1999 by The Endocrine Society RO 31-8220 Activates c-Jun N-Terminal Kinase and Glycogen Synthase in Rat Adipocytes and L6 Myotubes. Comparison to Actions of Insulin*

  year unknowncited by this paper

• Bioinformatics-based Prognosis Effect of Ferroptosis-related Genes on Gastric Cancer

  2025cites this paper
• Dual-specificity protein phosphatase 1: A potential therapeutic target in cancer

  2025influential citation
• DUSP1 Promotes Osimertinib Drug-Tolerant Persistence by Inhibiting MAPK/ERK Signaling in Non-small Cell Lung Cancer

  2024cites this paper
• DUSP1 and SOX2 expression determine squamous cell carcinoma of the salivary gland progression

  2024cites this paper
• Mitogen-Activated Protein Kinase Phosphatases: No Longer Undruggable?

  2023cites this paper
• Dual-specificity phosphatase 1 inhibits Singapore grouper iridovirus replication via regulating apoptosis in Epinephelus coioides.

  2023cites this paper
• Integrating scRNA and bulk-RNA sequencing develops a cell senescence signature for analyzing tumor heterogeneity in clear cell renal cell carcinoma

  2023cites this paper
• Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance

  2022cites this paper
• Transcriptional epigenetic regulation of Fkbp1/Pax9 genes is associated with impaired sensitivity to platinum treatment in ovarian cancer

  2021cites this paper
• Circular RNA 0006349 Augments Glycolysis and Malignance of Non-small Cell Lung Cancer Cells Through the microRNA-98/MKP1 Axis

  2021cites this paper
• Glutamine Inhibits TNF-α-induced Cytosolic Phospholipase A2 Activation via Upregulation of MAPK Phosphatase-1

  2021cites this paper
• Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance.

  2021cites this paper
• A Novel Role for the Tumor Suppressor Gene ITF2 in Tumorigenesis and Chemotherapy Response

  2020cites this paper
• A novel role for the tumor suppressor geneITF2in lung tumorigenesis and chemotherapy response

  2020cites this paper
• Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment

  2020cites this paper
• A novel role for the tumor suppressor gene ITF2 in lung tumorigenesis through the action of Wnt signaling pathway

  2019cites this paper
• Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma

  2019cites this paper
• Interplay of MKP-1 and Nrf2 drives tumor growth and drug resistance in non-small cell lung cancer

  2019cites this paper
• Dual-specificity MAP kinase phosphatases in health and disease

  2019cites this paper
• Deubiquitinating enzyme USP33 restrains docetaxel-induced apoptosis via stabilising the phosphatase DUSP1 in prostate cancer

  2019cites this paper
• MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species

  2018cites this paper
• DUSP1 induces apatinib resistance by activating the MAPK pathway in gastric cancer

  2018cites this paper
• NSC 95397 Suppresses Proliferation and Induces Apoptosis in Colon Cancer Cells through MKP-1 and the ERK1/2 Pathway

  2018cites this paper
• l-Glutamine Attenuates DSS-Induced Colitis via Induction of MAPK Phosphatase-1

  2018cites this paper
• Molecular mechanisms of cholangiocarcinoma progression: emphasizing the role of tumor-stroma interactions

  2018influential citation
• Suppresses Proliferation and Induces Apoptosis in Colon Cancer Cells through MKP-1 and the ERK 1 / 2 Pathway

  2018cites this paper
• Cancerous inhibitor of protein phosphatase 2A regulates cisplatin resistance in ovarian cancer.

  2018cites this paper
• Mkp‐1 cross‐talks with Nrf2/Ho‐1 pathway protecting against intestinal inflammation

  2018cites this paper
• DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer

  2017cites this paper
• High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response

  2017cites this paper
• DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through MAFG Overexpression in Cancer Cells

  2017cites this paper
• MKP-1 suppresses PARP-1 degradation to mediate cisplatin resistance

  2017cites this paper
• Phosphatases and solid tumors: focus on glioblastoma initiation, progression and recurrences.

  2017cites this paper
• MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets

  2017cites this paper
• Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy

  2016cites this paper
• Erratum to: APC selectively mediates response to chemotherapeutic agents in breast cancer

  2016cites this paper
• Role for DUSP1 (dual-specificity protein phosphatase 1) in the regulation of autophagy

  2016cites this paper
• Regulation of mitochondrial functions by protein phosphorylation and dephosphorylation

  2016cites this paper
• Dual-specificity Phosphatase 1 Deficiency Induces Endometrioid Adenocarcinoma Progression via Activation of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Pathway

  2016cites this paper
• Dual-Specificity Map Kinase (MAPK) Phosphatases (MKPs) and Their Involvement in Cancer

  2016cites this paper
• APC selectively mediates response to chemotherapeutic agents in breast cancer

  2015cites this paper
• MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells

  2015cites this paper
• Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation

  2015influential citation
• Phosphotyrosine Substrate Sequence Motifs for Dual Specificity Phosphatases

  2015cites this paper
• FOXM1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and mediates sensitivity to cisplatin in A549 cells via the JNK/mitochondrial pathway.

  2015cites this paper
• Dual specificity phosphatase 1 expression inversely correlates with NF‐κB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism

  2014cites this paper
• Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize NSCLC cells to cisplatin

  2014cites this paper
• Protein tyrosine phosphatases as potential therapeutic targets

  2014cites this paper
• Cancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populations

  2014cites this paper
• Estudio de la resistencia a quimioterapia en células con características de cancer stem cells (CSC) derivadas de cáncer no microcítico de pulmón (CNMP)

  2013cites this paper
• IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer

  2013cites this paper
• Downregulation of insulin-like growth factor-binding protein 7 in cisplatin-resistant non-small cell lung cancer

  2012cites this paper
• Efecto de la doxorubicina sobre MKP-1 en el cáncer de mama humano y asociación entre la expresión de MKP-1 y la evolución de las pacientes

  2012cites this paper
• S-Nitrosylation of mitogen activated protein kinase phosphatase-1 suppresses radiation-induced apoptosis.

  2012cites this paper
• Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease.

  2012cites this paper
• Decreased Total MKP-1 Protein Levels Predict Poor Prognosis in Breast Cancer

  2012cites this paper
• Regulation of the p38 mitogen-activated protein kinase and dual-specificity phosphatase 1 feedback loop modulates the induction of interleukin 6 and 8 in cells infected with coronavirus infectious bronchitis virus

  2011cites this paper
• DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer

  2011cites this paper
• Balance between MKK6 and MKK3 Mediates p38 MAPK Associated Resistance to Cisplatin in NSCLC

  2011cites this paper
• The dual-specificity protein phosphatase MkpB, homologous to mammalian MKP phosphatases, is required for D. discoideum post-aggregative development and cisplatin response.

  2011cites this paper
• Understanding the mechanism of CREB overexpression in pediatric acute myeloid leukemia

  2011cites this paper
• Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells

  2011cites this paper
• ICER Evokes Dusp1-p38 Pathway Enhancing Chemotherapy Sensitivity in Myeloid Leukemia

  2011cites this paper
• Dual-specificity MAP kinase phosphatases as targets of cancer treatment.

  2011cites this paper
• Lung Cancer Resistance to Chemotherapy

  2010cites this paper
• The dual-specificity MAP kinase phosphatases: critical roles in development and cancer.

  2010cites this paper
• Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.

  2010influential citation
• Tyrosine Phosphatase Inhibitor-3 Sensitizes Melanoma and Colon Cancer to Biotherapeutics and Chemotherapeutics

  2010cites this paper
• Induction of MKP-1 prevents the cytotoxic effects of PI3K inhibition in hilar cholangiocarcinoma cells

  2010cites this paper
• IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer

  2010cites this paper
• Molecular Cancer apeutics linical Development sine Phosphatase Inhibitor-3 Sensitizes Melanoma and Ther on Cancer to Biotherapeutics and Chemotherapeutics

  2010cites this paper
• Mitogen-Activated Protein Kinase Phosphatase-1 in Human Breast Cancer Independently Predicts Prognosis and Is Repressed by Doxorubicin

  2009cites this paper
• MMP‐9 controls Schwann cell proliferation and phenotypic remodeling via IGF‐1 and ErbB receptor‐mediated activation of MEK/ERK pathway

  2009influential citation
• MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.

  2009cites this paper
• [Advance on the Role of Mitogen-activated Protein Kinase (MAPK) Signal Pathway in Non-small Cell Lung Cancer.].

  2009cites this paper
• Proteomics and Pathway Analysis Identifies JNK Signaling as Critical for High Linear Energy Transfer Radiation-induced Apoptosis in Non-small Lung Cancer Cells*S

  2009cites this paper
• Glutamine Protects Mice from Lethal Endotoxic Shock via a Rapid Induction of MAPK Phosphatase-11

  2009cites this paper
• Dual-specificity phosphatases: critical regulators with diverse cellular targets.

  2009cites this paper
• MAPK Phosphatase-1 Endotoxic Shock via a Rapid Induction of Glutamine Protects Mice from Lethal

  2009cites this paper
• Involvement of MKP-1 and Bcl-2 in acquired cisplatin resistance in ovarian cancer cells

  2009cites this paper
• High-LET Radiation-induced Apoptosis in Non-Small Lung Cancer Cells

  2009cites this paper
• Analysis of ARE-binding proteins associated with 3′ untranslated region of MKP-1 mRNA.

  2009cites this paper
• Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway.

  2008cites this paper
• Dual-specificity MAP kinase phosphatases (MKPs) and cancer

  2008cites this paper
• Factor-{kappa}B Activity Nuclear 1 Pathway Augments the Apoptosis of GH4C1 Cells by Down-Regulating Thyroid Hormone-Mediated Activation of the ERK/Dual Specificity Phosphatase

  2008cites this paper
• In vivo identification of novel STAT5 target genes

  2008cites this paper
• Thyroid hormone-mediated activation of the ERK/dual specificity phosphatase 1 pathway augments the apoptosis of GH4C1 cells by down-regulating nuclear factor-kappaB activity.

  2008cites this paper
• MAPK phosphatases as novel targets for rheumatoid arthritis

  2008cites this paper
• Epidermal growth factor receptor and glioblastoma multiforme: molecular basis for a new approach

  2008cites this paper
• Mitogen-activated Protein Kinase Phosphatase-1 Represses c-Jun NH2-terminal Kinase-mediated Apoptosis via NF-κB Regulation*

  2008cites this paper
• Knockdown of Snail, a novel zinc finger transcription factor, via RNA interference increases A549 cell sensitivity to cisplatin via JNK/mitochondrial pathway.

  2008cites this paper
• Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses

  2007cites this paper
• Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer

  2007cites this paper
• Inhibition of the Canonical IKK/NFκB Pathway Sensitizes Human Cancer Cells to Doxorubicin

  2007cites this paper
• Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer

  2007cites this paper
• Human recombinant erythropoietin does not promote cancer growth in presence of functional receptors expressed in cancer cells

  2007cites this paper
• ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells.

  2007cites this paper
• Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin.

  2007cites this paper
• Apoptotic signaling pathways in lung cancer.

  2007cites this paper
• Signalling pathways involved in clinical responses to chemotherapy

  2007cites this paper